Abbott Laboratories (ABT) Annual Income Statement (USD)
ABT Quarterly Financials (USD)
Frequently Asked Questions About Abbott Laboratories (ABT) Stock
Abbott Laboratories's (ABT) last reported annual revenue was USD 40.11 Billion.
Abbott Laboratories's (ABT) annual revenue growth rate based on the revenue reported in the past 5 years is : -1.42%
Abbott Laboratories's(ABT) is profitable as of its last reported annual financials.
The net profit margin for Abbott Laboratories's(ABT) from its laster reported year is 14.27%
The return on equity (ROE) for Abbott Laboratories's(ABT) from its last reported annual financials is : 14.84%
The return on assets (ROA) for Abbott Laboratories's(ABT) from its last reported annual financials is : 6.49%
The return on invested capital (ROIC) for Abbott Laboratories's(ABT) from its last reported annual financials is : 10.37%
The Debt to Equity ratio for Abbott Laboratories's(ABT) from its last reported annual financials is : 35.23%
The dividend yield for Abbott Laboratories's(ABT) from its laster reported year is 1.90%
Abbott Laboratories's(ABT) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ABT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
